Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04139291
Other study ID # 09.2019.866
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 20, 2019
Est. completion date March 30, 2020

Study information

Verified date October 2019
Source Marmara University
Contact Esra Giray, MD
Phone +902166570606162
Email girayesra@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate tissue changes via ultrasound after complex decongestive therapy.


Description:

Lymphedema can be defined as the abnormal accumulation of protein-rich interstitial fluid that occurs primarily as a consequence of malformation, dysplasia, or acquired disruption of lymphatic circulation. Lymph stasis, which results in peripheral lymphedema, is characterized by edema and adipose tissue proliferation. As a vicious cycle of lymphedema progression, lymph stasis stimulates chronic inflammation because of uncontrolled responses of macrophages and CD4+ (cluster of differentiation 4) cells; fat accumulation also causes chronic inflammation by infiltration and activation of macrophages that produce inflammatory cytokines, which further promote lymph stasis directly or indirectly by decreasing lymphatic pumping and increasing capillary filtration. Lymphedema secondary to breast cancer is caused by the disruption of the lymphatic system, which in the initial stages leads to the accumulation of fluid in the interstitial tissue space and eventually is clinically presented as swelling of the arm, shoulder, neck, or torso. Complex decongestive physical therapy is a widely used nonoperative treatment of breast cancer-related lymphedema. The extremity volume has been one of the major parameters representing the treatment results of complex decongestive physical therapy. However, the increase in extremity volume in lymphedema can be caused both by tissue fluid accumulation and by pathologic tissue proliferation, which cannot be assessed separately at present. Accordingly, the volume or circumference measurement alone may not clarify how these phenomena are modified by complex decongestive physical therapy. Suehiro et al. developed subcutaneous echogenicity grade (SEG) and subcutaneous echo-free space (SEFS) grade via B-mode ultrasonography, allowing semiquantitation of nonspecific subcutaneous tissue inflammation and fluid accumulation. Increase in SEG is attributed to increased cell density and increased collagen content in the tissue and it is considered to indicate the presence of ongoing or previous inflammation in the area. SEFS represents the fluid accumulated in the spaces between superficial fasciae, which is freely mobile in the spaces. Recently, Suehiro et al. have investigated the impact of aggressive decongestion in limbs with lymphedema without SEFS in subcutaneous tissue ultrasonography. According to their results, the impact of aggressive decongestion seemed limited in patients with lymphedema without SEFS. But it was a retrospective study which may be a limitation to draw a firm conclusion. Therefore, the aim of this study is to evaluate tissue changes via ultrasound after complex decongestive therapy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date March 30, 2020
Est. primary completion date March 20, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

-Patients with unilateral postmastectomy lymphedema with a International Society of Lymphology-ISL) stage 2 and 3

Exclusion Criteria:

- Bilateral lymphedema

- The patients who had known systemic edematogenic conditions (e.g., cardiac/hepatic/renal failure, terminal cancer, on chemotherapy), and/or with cancer recurrence

- Patients with contraindications for application of complex decongestive therapy (active cutaneous infection, deep vein thrombosis, cardiac edema, and peripheral artery disease)

Study Design


Intervention

Other:
Complex decongestive therapy phase 1
Complex decongestive therapy-phase 1 program consist of meticulous skin and nail care, manuel lymphatic drainage, compression bandages, and remedial exercises. All patients will receive manual lymphatic drainage for three times a week (Monday-Wednesday-Friday) during 4 weeks, 50 minutes a day (a total of 12 sessions) by a trained lymphatic massage therapist.

Locations

Country Name City State
Turkey Esra Giray Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Marmara University

Country where clinical trial is conducted

Turkey, 

References & Publications (5)

Giray E, Yagci I. Diagnostic accuracy of interlimb differences of ultrasonographic subcutaneous tissue thickness measurements in breast cancer-related arm lymphedema. Lymphology. 2019;52(1):1-10. — View Citation

Giray E, Yagci I. Interrater and Intrarater Reliability of Subcutaneous Echogenicity Grade and Subcutaneous Echo-Free Space Grade in Breast Cancer-Related Lymphedema. Lymphat Res Biol. 2019 Oct;17(5):518-524. doi: 10.1089/lrb.2018.0053. Epub 2018 Dec 20. — View Citation

Sezgin Ozcan D, Dalyan M, Unsal Delialioglu S, Duzlu U, Polat CS, Koseoglu BF. Complex Decongestive Therapy Enhances Upper Limb Functions in Patients with Breast Cancer-Related Lymphedema. Lymphat Res Biol. 2018 Oct;16(5):446-452. doi: 10.1089/lrb.2017.00 — View Citation

Suehiro K, Morikage N, Ueda K, Samura M, Takeuchi Y, Nagase T, Mizoguchi T, Hamano K. Aggressive Decongestion in Limbs with Lymphedema without Subcutaneous Echo-Free Space. Ann Vasc Surg. 2018 Nov;53:205-211. doi: 10.1016/j.avsg.2018.04.033. Epub 2018 Aug — View Citation

Suehiro K, Morikage N, Yamashita O, Harada T, Samura M, Takeuchi Y, Mizoguchi T, Nakamura K, Hamano K. Skin and Subcutaneous Tissue Ultrasonography Features in Breast Cancer-Related Lymphedema. Ann Vasc Dis. 2016;9(4):312-316. doi: 10.3400/avd.oa.16-00086 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Subcutaneous Echogenicity Grade (SEG) medial forearm (MFA) Medial forearm (MFA): from the medial side of the forearm to the brachioradial muscle before treatment (T0)
Primary Subcutaneous Echo-Free Space Grade (SEFS) medial forearm (MFA) Medial forearm (MFA): from the medial side of the forearm to the brachioradial muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS before treatment (T0)
Primary Subcutaneous tissue thickness measurement via ultrasound over medial forearm (MFA) SEG grade of medial forearm (MFA): from the medial side of the forearm to the brachioradial muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Primary Subcutaneous Echogenicity Grade (SEG) medial forearm (MFA) SEG grade of medial forearm (MFA): from the medial side of the forearm to the brachioradial muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Primary Subcutaneous Echo-Free Space Grade (SEFS) medial forearm (MFA) Medial forearm (MFA): from the medial side of the forearm to the brachioradial muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Primary Subcutaneous tissue thickness measurement via ultrasound over medial forearm (MFA) Medial forearm (MFA): from the medial side of the forearm to the brachioradial muscle after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Limb volume measurement Limb volume will be calculated based on truncated cone method from circumference measurements before treatment (T0)
Secondary Limb volume measurement Limb volume will be calculated based on truncated cone method from circumference measurements after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous Echogenicity Grade (SEG) Medial upper arm (MUA) SEG grade of medial upper arm (MUA): from the medial side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary Subcutaneous Echo-Free Space Grade (SEFS) Medial upper arm (MUA) Medial upper arm (MUA): from the medial side of the upper arm to the biceps brachii muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS before treatment (T0)
Secondary Subcutaneous tissue thickness measurement via ultrasound over medial upper arm (MUA) SEG grade of medial upper arm (MUA): from the medial side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary SEG grade of medial upper arm (MUA) SEG grade of medial upper arm (MUA): from the medial side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous Echo-Free Space Grade (SEFS) Medial upper arm (MUA) Medial upper arm (MUA): from the medial side of the upper arm to the biceps brachii muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous tissue thickness measurement via ultrasound over medial upper arm (MUA) Medial upper arm (MUA): from the medial side of the upper arm to the biceps brachii muscle after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous Echogenicity Grade (SEG) Lateral upper arm (LUA) SEG grade of lateral upper arm (LUA): from the lateral side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary SEFS Lateral upper arm (LUA) Lateral upper arm (LUA): from the lateral side of the upper arm to the biceps brachii muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS before treatment (T0)
Secondary Subcutaneous tissue thickness measurement via ultrasound over lateral upper arm (LUA) SEG grade of lateral upper arm (LUA): from the lateral side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary Subcutaneous Echogenicity Grade (SEG) Lateral upper arm (LUA) SEG grade of lateral upper arm (LUA): from the lateral side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary SEFS Lateral upper arm (LUA) Lateral upper arm (LUA): from the lateral side of the upper arm to the biceps brachii muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous tissue thickness measurement via ultrasound over lateral upper arm (LUA) SEG grade of lateral upper arm (LUA): from the lateral side of the upper arm to the biceps brachii muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous Echogenicity Grade (SEG) Lateral forearm (LFA) SEG grade of lateral forearm (LFA): from the lateral side of the forearm to the brachioradial muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary SEFS Lateral forearm (LFA) Lateral forearm (LFA): from the lateral side of the forearm to the brachioradial muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS before treatment (T0)
Secondary Subcutaneous tissue thickness measurement via ultrasound over lateral forearm (LFA) SEG grade of lateral forearm (LFA): from the lateral side of the forearm to the brachioradial muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary SEG grade of lateral forearm (LFA) SEG grade of lateral forearm (LFA): from the lateral side of the forearm to the brachioradial muscle Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary SEFS Lateral forearm (LFA) Lateral forearm (LFA): from the lateral side of the forearm to the brachioradial muscle SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous tissue thickness measurement via ultrasound over lateral forearm (LFA) Lateral forearm (LFA): from the lateral side of the forearm to the brachioradial muscle after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous Echogenicity Grade (SEG) Dorsum of the hand (DH) SEG grade of Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand.
Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable.
before treatment (T0)
Secondary SEFS Dorsum of the hand (DH) Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand. SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS before treatment (T0)
Secondary Subcutaneous tissue thickness measurement via ultrasound over dorsum of the hand (DH) SEG grade of Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand.
Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable.
before treatment (T0)
Secondary SEG dorsum of the hand (DH) SEG grade of Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand.
Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable.
after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary SEFS Dorsum of the hand (DH) Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand. SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary SEG grade of Dorsum of the hand (DH) Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand. SEG grade of Dorsum of the hand (DH): on the first dorsal interosseous muscle of the hand.
Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable.
after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous Echogenicity Grade (SEG) wrist SEG grade over wrist Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. before treatment (T0)
Secondary SEFS wrist SEFS grade over wrist SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS before treatment (T0)
Secondary Subcutaneous tissue thickness measurement via ultrasound over wrist Subcutaneous tissue thickness measurement via ultrasound over wrist before treatment (T0)
Secondary Subcutaneous Echogenicity Grade (SEG) wrist SEG grade over wrist Grade 0: No or little increase in echogenicity in the subcutaneous layer. Horizontal or obliquely oriented echogenic lines caused by connective tissue bundles are clearly observed. Grade 1: Diffused and monotonous increases in echogenicity in the subcutaneous layer. Echogenic lines are unclear but identifiable. Grade 2: Diffused increases in echogenicity. Echogenic lines are not identifiable. after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary SEFS wrist SEFS grade over wrist SEFS grade Grade 0: No SEFS. Grade 1: Horizontally oriented (<45 degrees to the skin) SEFS only. Grade 2: Presence of vertically oriented (‡45 degrees to the skin) SEFS bridging the horizontally oriented SEFS after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
Secondary Subcutaneous tissue thickness measurement via ultrasound over wrist Subcutaneous tissue thickness measurement via ultrasound over wrist after treatment (T1) (through completion of four weeks of complex decongestive therapy phase 1)
See also
  Status Clinical Trial Phase
Completed NCT03492476 - Circaid® Compression Sleeve Versus Short-stretching Bandage in Upper Limb Lymphatic Edema N/A
Completed NCT03676127 - Diagnostic Accuracy of Dermal Thickness in Lymphedema
Completed NCT04570722 - Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study) N/A
Completed NCT06230913 - Kinesiotaping Versus Pressure Garments on Secondary Upper Extremity Lymphedema. N/A
Recruiting NCT03210311 - Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema N/A
Not yet recruiting NCT04435639 - Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema N/A
Active, not recruiting NCT02691624 - Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation
Recruiting NCT04138667 - Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema N/A
Recruiting NCT04296929 - The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema. N/A
Recruiting NCT06144164 - A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer Phase 3
Completed NCT05278871 - Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors N/A
Not yet recruiting NCT06407791 - Clinical Evaluation of a Device for Treatment of Lymphedema of the Upper Extremity N/A
Recruiting NCT04908254 - A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema N/A
Completed NCT04881604 - Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema N/A
Recruiting NCT05203835 - Trial of Acebilustat for the Treatment of Upper Arm Lymphedema Phase 2
Recruiting NCT04934098 - Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema N/A
Recruiting NCT04203069 - Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase N/A
Withdrawn NCT04246034 - Microvascular Breast Reconstruction With Lymph Node Transfer N/A
Completed NCT04213001 - Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema N/A
Recruiting NCT04690439 - Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema N/A